Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1996 Sep;13(9):1336-42.
doi: 10.1023/a:1016065715308.

Comparison between permeability coefficients in rat and human jejunum

Affiliations
Comparative Study

Comparison between permeability coefficients in rat and human jejunum

U Fagerholm et al. Pharm Res. 1996 Sep.

Abstract

Purpose: Our main aim is to determine the effective intestinal permeability (Peff) in the rat jejunum in situ for 10 compounds with different absorption mechanisms and a broad range of physico chemical properties, and then compare them with corresponding historical human in vivo Peff values.

Methods: The rat Peff coefficients are determined using an in situ perfusion model in anaesthetized animals. The perfusion flow rate used is 0.2 ml/min, which is 10 times lower than that used in humans. The viability of the method is assessed by testing the physiological function of the rat intestine during perfusions.

Results: The Peff for passively absorbed compounds is on average 3.6 times higher in humans compared to rats (Peff, man = 3.6 x Peff.rat+ 0.03.10(-4); R]2 = 1.00). Solutes with carrier-mediated absorption deviate from this relationship, which indicates that an absolute scaling of active processes from animal to man is difficult, and therefore needs further investigation. The fraction absorbed of drugs after oral administration in humans (fa) can be estimated from 1-e-(-2.Peff,man t rex/r.2.8).

Conclusions: Rat and human jejunum Peff-estimates of passively absorbed solutes correlate highly, and both can be used with precision to predict in vivo oral absorption in man. The carrier-mediated transport requires scaling between the models, since the transport maximum and/or substrate specificity might differ. Finally, we emphasize the absolute necessity of including marker compounds for continuous monitoring of intestinal viability.

PubMed Disclaimer

References

    1. Pharm Res. 1991 Aug;8(8):979-88 - PubMed
    1. Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5 - PubMed
    1. Br J Clin Pharmacol. 1994 Jun;37(6):589-96 - PubMed
    1. Pharm Res. 1993 Jun;10(6):884-8 - PubMed
    1. Pharm Res. 1995 Mar;12(3):413-20 - PubMed

Publication types